XenoPort (XNPT) Tops Q4 EPS by 10c, Offers Guidance

XenoPort (NASDAQ: XNPT) reported Q4 EPS of ($0.21), $0.10 better than the analyst estimate of ($0.31). Revenue for the quarter came in at $14.1 million versus the consensus estimate of $13.74 million.

Financial Guidance

XenoPort announced that it expects HORIZANT net product sales for 2016 to be in the range of $61 million to $65 million. XenoPort expects research and development expenses to be in the range of $4 million to $6 million and selling, general and administrative expenses to be in the range of $100 million to $110 million, which includes employee non-cash stock-based compensation of approximately $10 million. Finally, XenoPort expects that the net use of cash for 2016 will be in the range of $40 million to $50 million (net use of cash is the difference between the anticipated balances of cash and cash equivalents plus short-term investments at December 31, 2016 and the actual balances at December 31, 2015).

For earnings history and earnings-related data on XenoPort (XNPT) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c